CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 65 filers reported holding CHEMOCENTRYX INC in Q4 2014. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,023,000 | -16.4% | 138,294 | -31.7% | 0.00% | 0.0% |
| Q3 2016 | $1,223,000 | +32.5% | 202,491 | -1.5% | 0.00% | 0.0% |
| Q2 2016 | $923,000 | +216.1% | 205,673 | +75.3% | 0.00% | – |
| Q1 2016 | $292,000 | -59.8% | 117,348 | +30.8% | 0.00% | -100.0% |
| Q4 2015 | $727,000 | +797.5% | 89,693 | +569.1% | 0.00% | – |
| Q3 2015 | $81,000 | -33.1% | 13,406 | -9.1% | 0.00% | – |
| Q2 2015 | $121,000 | +21.0% | 14,743 | +11.3% | 0.00% | – |
| Q1 2015 | $100,000 | +38.9% | 13,248 | +25.2% | 0.00% | – |
| Q4 2014 | $72,000 | +38.5% | 10,580 | -9.3% | 0.00% | – |
| Q3 2014 | $52,000 | -23.5% | 11,665 | 0.0% | 0.00% | – |
| Q2 2014 | $68,000 | -24.4% | 11,665 | -14.1% | 0.00% | – |
| Q1 2014 | $90,000 | +28.6% | 13,576 | +13.0% | 0.00% | – |
| Q4 2013 | $70,000 | -71.8% | 12,012 | -73.1% | 0.00% | – |
| Q3 2013 | $248,000 | -74.4% | 44,599 | -34.8% | 0.00% | -100.0% |
| Q2 2013 | $967,000 | – | 68,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |